Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1388-1394

  Koshy, Matthew ^a   Goloubeva, Olga ^a   Suntharalingam, Mohan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Neoadjuvant radiation; SEER; Stage III

Indexed keywords

CAUSE-SPECIFIC SURVIVAL; CONFIDENCE INTERVAL; COX MODEL; COX REGRESSION; DEFINITIVE THERAPY; HAZARD RATIO; KAPLAN-MEIER METHOD; LUNG CANCER; MULTI VARIABLES; NEOADJUVANT RADIATION; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RADIATION THERAPY; REGRESSION MODEL; SEER; SURVIVAL FUNCTION; TREATMENT GROUP;

BIOLOGICAL ORGANS; DISEASES; RADIATION; REGRESSION ANALYSIS; SURGERY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 79952702682     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.066     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899-909.
3. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-2699. (Pubitemid 29415225)
4. van Meerbeeck JP, Meersschout S, De Pauw R, et al. Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: Present status and future prospects. Oncologist 2008;13:700-708. (Pubitemid 351904914)
5. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
6. Choi NC, Carey RW, Daly W, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 1997;15:712-722. (Pubitemid 27074241)
7. Elias AD, Skarin AT, Leong T, et al. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer 1997;17:147-161. (Pubitemid 27261499)
8. Burkes RL, Shepherd FA, Blackstein ME, et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: Final results of the Toronto phase II trial. Lung Cancer 2005;47:103-109. (Pubitemid 39643247)
9. Edelman MJ, Suntharalingam M, Burrows W, et al. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer. Ann Thorac Surg 2008;86:903-910.
10. Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial. Lancet 2009;374:379-386.
11. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-450. (Pubitemid 47073567)
12. Maas KW, El Sharouni SY, Smit EF, et al. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer. Curr Opin Pulm Med 2007;13:297-304. (Pubitemid 46847295)
13. Vandenbroucke E, De Ryck F, Surmont V, et al. What is the role for surgery in patients with stage III non-small cell lung cancer? Curr Opin Pulm Med 2009;15:295-302.
14. Steger V, Walles T, Kosan B, et al. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: Mid-term results and indicators for survival. Ann Thorac Surg 2009;87:1676-1683.
15. Grunenwald DH, Andre F, Le Pechoux C, et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2001;122:796-802.
16. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup trial 0160). J Clin Oncol 2007;25:313-318. (Pubitemid 350003020)
17. Rusch VW, Albain KS, Crowley JJ, et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 1993;105(97):104, discussion 104-106.
18. Fujita S, Katakami N, Takahashi Y, et al. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 2006;29:896-901. (Pubitemid 43728584)
19. Perrot E, Guibert B, Mulsant P, et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg 2005;80:423-427. (Pubitemid 41019453)
20. Fowler WC, Langer CJ, Curran WJ, Jr., et al. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993;55:986-989. (Pubitemid 23130257)
21. Sonett JR, Krasna MJ, Suntharalingam M, et al. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 1999;68:316-320. (Pubitemid 29521068)
22. Yu JB, Gross CP, Wilson LD, et al. NCI SEER public-use data: Applications and limitations in oncology research. Oncology 2009;23:288-295.
23. Chee KG, Nguyen DV, Brown M, et al. Positron emission tomography and improved survival in patients with lung cancer: The Will Rogers phenomenon revisited. Arch Intern Med 2008;168:1541-1549.
24. Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006. (Pubitemid 46638932)